Sudarshan Pharma Industries Ltd
NSE: BSE: 543828
₹34.19
(4.97%)
Mon, 25 May 2026, 06:03 pm
Market Cap7.84B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSudarshan Pharma Industries Cashflow
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Deprecation and amortization | -3.47M | -7.42M | -8.66M | -9.07M | -12.44M | -22.21M |
| Accumulated depreciation, total | -6.28M | -12.52M | -17.39M | -21.74M | -31.42M | -42.07M |
| Cash from operating activities | -58.30M | -79.88M | -66.20M | -293.69M | -688.05M | -454.27M |
| Funds from operations | 21.70M | 34.76M | 62.33M | 82.97M | 143.19M | 239.76M |
| Net income (cash flow) | 12.75M | 26.71M | 52.48M | 70.37M | 114.55M | 159.55M |
| Depreciation & amortization (cash flow) | 3.47M | 7.42M | 8.66M | 9.07M | 12.44M | 22.21M |
| Depreciation/depletion | 3.25M | 6.24M | 7.52M | 8.05M | 9.45M | 10.65M |
| Amortization | 218.00K | 1.19M | 1.14M | 1.02M | 3.00M | 11.56M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 1.07M | -8.41M | -17.68M | -21.06M | -21.54M | 1.25M |
| Changes in working capital | -80.00M | -114.64M | -128.53M | -376.66M | -831.23M | -694.03M |
| Cash from investing activities | -25.39M | -12.71M | -17.05M | -261.42M | -80.20M | -212.08M |
| Capital expenditures | -24.10M | -13.20M | -16.56M | -138.03M | -55.23M | -47.46M |
| Capital expenditures - fixed assets | -24.10M | -13.20M | -16.56M | -138.03M | -37.84M | -47.46M |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 | -17.39M | — |
| Cash from financing activities | 60.79M | 92.45M | 73.06M | 669.93M | 652.49M | 670.04M |
| Free cash flow | -82.41M | -93.08M | -82.77M | -431.71M | -725.89M | -501.74M |